Press release
Biguanides Global Market Sales Estimated to Hit $5.76 Billion at a CAGR of 3.8% By 2028 | Cardinal Health Inc., Pfizer Inc., Merck And Co Inc., Bayer AG, Novartis AG
Biguanides Market
As per the report, the biguanides market size has grown steadily in recent years. It will grow from $4.79 billion in 2023 to $4.96 billion in 2024 at a compound annual growth rate (CAGR) of 3.6%. The biguanides market size is expected to see steady growth in the next few years. It will grow to $5.76 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp
Impact Of Rising Diabetes Prevalence On Biguanides
The rise in diabetes is expected to propel the growth of the biguanides market going forward. Diabetes refers to a chronic metabolic disorder characterized by high levels of blood sugar (glucose) resulting from the body's inability to produce enough insulin. Rising diabetes is driven by several factors, including lifestyle changes, population aging, genetic predisposition, improved diagnosis, and environmental influences. Biguanides, such as metformin, mitigate diabetes by improving insulin sensitivity, reducing glucose production in the liver, and lowering blood sugar levels in individuals with type 2 diabetes. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported. Therefore, the rising prevalence of diabetes is driving the growth of the biguanides market.
Advancements In Extended-Release Biguanides For Enhanced Diabetes Management
Major companies operating in the biguanide market are focused on developing advanced solutions, such as extended-release biguanide drugs, to improve patient compliance, enhance therapeutic efficacy, and reduce side effects. An extended-release biguanide is a medication formulated to slowly release its active component, ensuring consistent blood levels and better glycemic control for diabetes patients, thereby improving adherence to the treatment. For instance, in August 2023, Dr. Reddy's Laboratories, an India-based biotechnology company, launched saxagliptin and metformin hydrochloride extended-release drugs. This is a generic version of KOMBIGLYZE XR, approved by the US Food and Drug Administration (USFDA), which combines saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide. It is designed to enhance glycemic control in adults with type 2 diabetes mellitus and is intended for use alongside diet and exercise. The extended-release formulation helps improve patient adherence and efficacy.
The biguanides market covered in this report is segmented -
1) By Type: Metformin, Phenformin, Other Types
2) By Dosage Form: Tablets, Oral Solutions
3) By Formulation: Immediate Release, Extended Release
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15735&type=discount
Major companies operating in the biguanides market are Cardinal Health Inc., Pfizer Inc., Merck And Co Inc, Bayer AG, Sanofi-Aventis LLC, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Company Limited, Novo Nordisk A/S, Viatris Inc., Daiichi Sankyo Company Limited, Wanbury Ltd, Boehringer Ingelheim International GmbH, Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Cipla Ltd, Shionogi & Co Ltd, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Apotex Inc, Torrent Pharmaceuticals Limited, Panacea Biotech Ltd., Auro Laboratories Limited
Contents of the report:
1. Executive Summary
2. Biguanides Market Report Structure
3. Biguanides Market Trends And Strategies
4. Biguanides Market - Macro Economic Scenario
5. Biguanides Market Size And Growth
…..
27. Biguanides Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biguanides Global Market Sales Estimated to Hit $5.76 Billion at a CAGR of 3.8% By 2028 | Cardinal Health Inc., Pfizer Inc., Merck And Co Inc., Bayer AG, Novartis AG here
News-ID: 3582598 • Views: …
More Releases from The Business research company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Biguanides
Biguanides Market Growth Accelerates: Strategic Forecast Predicts $5.81 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Biguanides Industry Market Size Be by 2025?
The market size of biguanides has experienced steady expansion in the past few years. The market, valued at $4.96 billion in 2024, is predicted to reach $5.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.1%.…
Biguanides Market Expansion Continues, with Forecast Valuation of $5.98 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biguanides Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recent years have witnessed a consistent expansion in the biguanides market. It is projected to increase from $4.96 billion in 2024 to $5.16 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.1%. The…
Biguanides Market Is Booming Worldwide with Glenmark, Merck, Zydus
Global Biguanides market size, trend, and forecast to 2030 are assessed in USD Analytics Research's most recent analysis. A valuable resource document for managers, analysts, industry experts, and other key personnel, the Biguanides market study includes substantial research data and proofs to help them understand market trends, growth drivers, opportunities, upcoming challenges, and competitors. The study can be easily accessed and self-analyzed.
Key Players in This Report Include:
Boehringer Ingelheim, Bristol-Myers…
Biguanides Market Size Worth $ 6.19 Billion By 2032; Registering at a CAGR of 2. …
𝐁𝐢𝐠𝐮𝐚𝐧𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Biguanides are a class of organic compounds with a specific chemical structure characterized by two nitrogen atoms. One of the well-known biguanides is metformin, a widely used medication for the treatment of type 2 diabetes. Beyond pharmaceutical applications, biguanides have applications in various industries, including agriculture and water treatment.
The global Biguanides market size is expected to reach USD 6.19 billion by 2032, according to a new study by…
Antidiabetic Biguanides Market Opportunities, Sales, Revenue, Gross Margin & Tre …
Antidiabetic Biguanides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidiabetic Biguanides market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Antidiabetic Biguanides Market: Driven factors and Restrictions factors
The research report…
Antidiabetic Biguanides Market- Industry Analysis, Size, Share, Growth And Forec …
The Global Antidiabetic Biguanides Market Research Report 2017 renders deep perception of the key regional market status of the Antidiabetic Biguanides Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
Request For Sample Of Antidiabetic Biguanides Market Research Report @ https://www.qyresearchgroups.com/request-sample/426282
The report on “Global Antidiabetic Biguanides Market”…
